Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net loss	$ (12,026,766)	$ (2,837,155)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization	1,357,571	371,435
Share-based compensation	643,570	176,045
Accretion of notes payables	48,070	0
Warrant amortization	0	45,527
PPP loan forgiveness	0	(1,369,100)
Gain on extinguishment of debt	0	(14,960)
Inventory allowance	0	12,794
Changes in assets and liabilities:
Accounts receivable	542,035	(13,201)
Inventories	(233,911)	(458,175)
Prepaid expenses	862,375	(1,086,971)
Accounts payable and accrued expenses	761,948	354,385
Operating leases	(1,203,295)	0
Net cash used in operating activities	(9,248,403)	(4,819,376)
Cash flows from investing activities
Purchases of property, plant, and equipment	(549,850)	(393,359)
Net cash used in investing activities	(549,850)	(393,359)
Cash flows from financing activities
Proceeds from notes payable and factoring agreement	9,070,726	5,097,870
Proceeds from equity financing	4,765,232	0
Proceeds from exercise of stock options	5,232	36,995
Principal payment of notes payable and recourse factoring agreement	(3,977,778)	(4,150,701)
Principal payment on finance lease	(985,622)	(100,839)
Repayment of finance insurance premiums	(53,115)
Proceeds from the APO	0	8,382,826
Proceeds from PPP loan	0	833,300
Net cash provided by financing activities	8,824,675	10,099,451
Net decrease in cash	(973,578)	4,886,716
Cash, beginning of period	5,313,985	427,269
Cash, end of period	4,340,407	5,313,985
Noncash transactions:
Property and equipment financed through finance leases	4,745,311	144,177
Other long-term asset additions included in accounts payable	2,369,612	0
Financing of insurance premiums and software	382,843	0
Right-of-use assets obtained through operating lease	327,400	0
Conversion of promissory notes to common stock	52,000	5,988,602
Property and equipment additions included in accounts payable	$ 15,873	$ 50,625